Report cover image

Live Attenuated Vaccines Global Market Report 2025

Published Jul 07, 2025
Length 175 Pages
SKU # BRC20166101

Description

Live Attenuated Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on live attenuated vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for live attenuated vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The live attenuated vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Vaccine Type: Monovalent; Multivalent

2) By Route Of Administration: Intramuscular; Subcutaneous; Oral Attenuated; Intranasal Attenuated

3) By Indication: Influenza; Measles, Mumps and Rubella (MMR); Polio; Chickenpox; Shingles; Rotavirus; Other Indications

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

5) By End-User: Hospitals; Clinics; Diagnostic Centers; Research Institute; Other End-Users

Subsegments:

1) By Monovalent: Single-Dose Vaccines; Multiple-Dose Vaccines

2) By Multivalent: Bivalent Vaccines; Trivalent Vaccines; Quadrivalent Vaccines; Other Multivalent Vaccines

Companies Mentioned: Merck & Co. Inc.; Sanofi SA; AstraZeneca plc; Abbott Laboratories; GlaxoSmithKline plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Live Attenuated Vaccines Market Characteristics
3. Live Attenuated Vaccines Market Trends And Strategies
4. Live Attenuated Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Live Attenuated Vaccines Growth Analysis And Strategic Analysis Framework
5.1. Global Live Attenuated Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Live Attenuated Vaccines Market Growth Rate Analysis
5.4. Global Live Attenuated Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Live Attenuated Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Live Attenuated Vaccines Total Addressable Market (TAM)
6. Live Attenuated Vaccines Market Segmentation
6.1. Global Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monovalent
Multivalent
6.2. Global Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intramuscular
Subcutaneous
Oral Attenuated
Intranasal Attenuated
6.3. Global Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Influenza
Measles, Mumps And Rubella (MMR)
Polio
Chickenpox
Shingles
Rotavirus
Other Indications
6.4. Global Live Attenuated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Live Attenuated Vaccines Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Diagnostic Centers
Research Institute
Other End-Users
6.6. Global Live Attenuated Vaccines Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-Dose Vaccines
Multiple-Dose Vaccines
6.7. Global Live Attenuated Vaccines Market, Sub-Segmentation Of Multivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bivalent Vaccines
Trivalent Vaccines
Quadrivalent Vaccines
Other Multivalent Vaccines
7. Live Attenuated Vaccines Market Regional And Country Analysis
7.1. Global Live Attenuated Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Live Attenuated Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Live Attenuated Vaccines Market
8.1. Asia-Pacific Live Attenuated Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Live Attenuated Vaccines Market
9.1. China Live Attenuated Vaccines Market Overview
9.2. China Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Live Attenuated Vaccines Market
10.1. India Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Live Attenuated Vaccines Market
11.1. Japan Live Attenuated Vaccines Market Overview
11.2. Japan Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Live Attenuated Vaccines Market
12.1. Australia Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Live Attenuated Vaccines Market
13.1. Indonesia Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Live Attenuated Vaccines Market
14.1. South Korea Live Attenuated Vaccines Market Overview
14.2. South Korea Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Live Attenuated Vaccines Market
15.1. Western Europe Live Attenuated Vaccines Market Overview
15.2. Western Europe Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Live Attenuated Vaccines Market
16.1. UK Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Live Attenuated Vaccines Market
17.1. Germany Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Live Attenuated Vaccines Market
18.1. France Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Live Attenuated Vaccines Market
19.1. Italy Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Live Attenuated Vaccines Market
20.1. Spain Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Live Attenuated Vaccines Market
21.1. Eastern Europe Live Attenuated Vaccines Market Overview
21.2. Eastern Europe Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Live Attenuated Vaccines Market
22.1. Russia Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Live Attenuated Vaccines Market
23.1. North America Live Attenuated Vaccines Market Overview
23.2. North America Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Live Attenuated Vaccines Market
24.1. USA Live Attenuated Vaccines Market Overview
24.2. USA Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Live Attenuated Vaccines Market
25.1. Canada Live Attenuated Vaccines Market Overview
25.2. Canada Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Live Attenuated Vaccines Market
26.1. South America Live Attenuated Vaccines Market Overview
26.2. South America Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Live Attenuated Vaccines Market
27.1. Brazil Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Live Attenuated Vaccines Market
28.1. Middle East Live Attenuated Vaccines Market Overview
28.2. Middle East Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Live Attenuated Vaccines Market
29.1. Africa Live Attenuated Vaccines Market Overview
29.2. Africa Live Attenuated Vaccines Market, Segmentation By Vaccines Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Live Attenuated Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Live Attenuated Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Live Attenuated Vaccines Market Competitive Landscape And Company Profiles
30.1. Live Attenuated Vaccines Market Competitive Landscape
30.2. Live Attenuated Vaccines Market Company Profiles
30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
31. Live Attenuated Vaccines Market Other Major And Innovative Companies
31.1. Takeda Pharmaceutical Company Limited
31.2. Boehringer Ingelheim International GmbH
31.3. CSL Limited
31.4. GC Biopharma
31.5. Serum Institute of India Pvt. Ltd.
31.6. Bavarian Nordic
31.7. Valneva SE
31.8. Southern Research
31.9. BioFarma
31.10. Bharat Biotech International Limited
31.11. Meissa Vaccines Inc.
31.12. BioDiem Ltd.
31.13. Bio-Med Limited
31.14. Lakshmi Pharmaceuticals
31.15. Biosynth AG
32. Global Live Attenuated Vaccines Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Live Attenuated Vaccines Market
34. Recent Developments In The Live Attenuated Vaccines Market
35. Live Attenuated Vaccines Market High Potential Countries, Segments and Strategies
35.1 Live Attenuated Vaccines Market In 2029 - Countries Offering Most New Opportunities
35.2 Live Attenuated Vaccines Market In 2029 - Segments Offering Most New Opportunities
35.3 Live Attenuated Vaccines Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.